Molecular targeting in inflammatory bowel disease : an investigation to identify novel chemokine targets for the potential development of new therapeutic agents for inflammatory bowel disease
Purpose Inflammatory bowel disease is characterised by intense mucosal recruitment of activated leukocytes. As chemokines determine inflammatory leukocyte recruitment and retention, the expression of the entire chemokine family within colonic mucosa from IBD patients was compared to non-inflamed and...
Main Author: | Puleston, Joanne Mary |
---|---|
Published: |
University College London (University of London)
2005
|
Subjects: | |
Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.420604 |
Similar Items
-
Therapeutic targets in inflammatory bowel disease
by: Daniela Fluxa, et al.
Published: (2019-07-01) -
Adaptation to Inflammatory Bowel Disease
by: Matini, Lawrence
Published: (2017) -
Genetic studies in inflammatory bowel disease
by: Hamlin, Peter John
Published: (2002) -
The role of heparin in inflammatory bowel disease
by: Shetty, Ajeya Krishna
Published: (2011) -
Microarray profiling of inflammatory bowel disease
by: Khodiyar, Varsha Kumari
Published: (2002)